A randomised controlled trial of acupuncture for the treatment of hyperventilation syndrome

Not Applicable

Completed

Conditions: Hyperventilation syndrome
Signs and Symptoms
Abnormalities of breathing

Registration Number: ISRCTN71727409

Lead Sponsor: Physiotherapy Research Foundation (UK)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 90

Inclusion Criteria

Any patient newly diagnosed with hyperventilation syndrome by the respiratory physicians at Southampton General Hospital.

Added as of 14/10/2008:
Both males and females, over 18 years old

Exclusion Criteria

1. Any person for whom acupuncture would be contraindicated e.g. in pregnancy, pacemaker wearers
2. Any person who is receiving conventional or alternative treatment for the condition
3. People who are allergic to sticking plaster
4. People who are unable to attend for the required treatment sessions

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospital Anxiety and Depression scale. This is a validated questionnaire which is used to identify anxiety and depression in non-psychiatric hospital clinics.<br><br>Added as of 14/10/2008:<br>All primary and secondary outcomes are measured at 1) baseline 2) pre-treatment (after a 4-week wait period to ensure participant's condition is stable) and 3) post-treatment on the 9th session.

Secondary Outcome Measures

Name	Time	Method
1. Nijmegen Questionnaire - this is a validated screening tool which has been shown to have 95% effectiveness in discriminating hyperventilators from normals<br>2. Measure Yourself Medical Outcome Profile (MYMOP2) - this is a validated quality of life measure, which is individualised and problem specific and also includes general wellbeing<br>3. Objective measures of cardiorespiratory performance will also be taken e.g. respiratory rate and pattern, resting end tidal carbon dioxide, pulse oximetry, pulse rate and blood pressure<br>4. Borkovec and Nau credibility rating - this will be used to assess the success of blinding<br><br>Added as of 14/10/2008:<br>All primary and secondary outcomes are measured at 1) baseline 2) pre-treatment (after a 4-week wait period to ensure participant's condition is stable) and 3) post-treatment on the 9th session.